Jakarta, August 26, 2025 – PT Revass Utama Medika successfully inaugurated its new Revass Headquarters, a significant milestone in celebrating its 15-year journey as one of Indonesia’s leading medical device distributors. The event was attended by more than 130 employees onsite and over 150 employees online, and was officiated by Andriatno Martono, President Director, together with Denise Lau, Chief Operating Officer, Jason Chen, Chief Finance Officer of OrbusNeich, and M. Zidni Ilma, Shareholder of PT Revass Utama Medika.
In his speech, Andriatno Martono, President Director of Revass, emphasized the significance of the modern headquarters while highlighting the company’s achievements.
“This modern headquarters is a pivotal milestone in our mission to raise the standards of healthcare services in Indonesia. Over the past 15 years, Revass has achieved numerous milestones, including international ISO certification about Quality Management System for Medical Devices and Anti-Bribery Management System, national GDPMD certification, and the prestigious Great Place to Work (GPTW) recognition, demonstrating our strong corporate culture and outstanding employee experience. With the global support of OrbusNeich, we are able to deliver advanced cardiovascular solutions that improve quality of life and contribute to a healthier Indonesia,” said Andriatno.
Andriatno Martono (President Director of Revass) deliver his speeches during the inauguration ceremony.
Designed to foster collaboration and innovation, the new Revass Headquarters is expected to become a hub for generating solutions to Indonesia’s healthcare challenges. It also supports OrbusNeich Group’s long-term strategy to deliver excellence in interventional medical devices, improve healthcare accessibility, and enhance quality of life.
Denise Lau, Executive Director and Chief Operating Officer of OrbusNeich also expressed appreciation for Revass’s rapid growth since joining the group.
“Since becoming part of OrbusNeich Medical Group in 2023, Revass has accelerated its expansion through various strategic initiatives. In 2024, we launched two subsidiaries, Kedung Artha Medika and Lumina—to broaden our portfolio and market reach. Today, Revass serves 93% of hospitals in Indonesia equipped with cath labs, a significant achievement in cardiovascular device distribution. Financially, our performance remains solid, with year-to-date revenue growth of around 40% as of June 2025, despite global economic challenges,” said Denise.
Speech of Ms. Denise Lau (Executive Director & COO of OrbusNeich)
She added that these achievements reflect the synergy between OrbusNeich’s global expertise and Revass’s local leadership in driving aggressive yet sustainable growth.
With the inauguration of this new headquarters, Revass reaffirms its commitment to strengthening its contribution to Indonesia’s healthcare sector, serving as a strategic partner for hospitals and medical professionals in delivering the best cardiovascular solutions.
Ribbon & Balloon Release – The symbolic inauguration of the Revass Headquarters marked by ribbon cutting and balloon release.
－ End －
